2024
Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG)
Kostka J, Maharjan A, Kumar S, Hackenyos D, Krause P, Dieckhaus K. Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG). PLOS Neglected Tropical Diseases 2024, 18: e0012035. PMID: 38484010, PMCID: PMC10965045, DOI: 10.1371/journal.pntd.0012035.Peer-Reviewed Original ResearchConceptsIntravenous immunoglobulinB. microti antibodiesBabesiosis patientsSpectrum of disease severityCommercial intravenous immunoglobulinEffective treatment strategiesSevere organ damageHost antibody responseImmunocompromised patientsAdjunctive therapyOrgan damageTreatment strategiesAcute andClinical trialsMicroti antibodiesAsymptomatic infectionAntibody responseTherapeutic benefitTherapeutic effectPatientsDisease severityAntibodiesImmunofluorescence assayProtozoan infectionsCommercial samples
1994
Quality Standard for the Treatment of Bacteremia
Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for the Treatment of Bacteremia. Infection Control And Hospital Epidemiology 1994, 15: 189-192. DOI: 10.2307/30145559.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsQuality Standards SubcommitteeInfectious Diseases SocietyTreatment of bacteremiaDiseases SocietyBlood culturesChart reviewersAdverse outcomesPediatric Infectious Diseases SocietyPlacebo-controlled trialPresence of bacteremiaSurgical Infection SocietySerious adverse outcomesAdministration of antibioticsAppropriate antimicrobial treatmentClinical Affairs CommitteeCase-control studyPositive blood culturesSpecific clinical indicationsAppropriate dosingHospitalized patientsRenal failureClinical trialsRisk factorsClinical indicationsHospital epidemiologyQuality standard for the treatment of bacteremia. The Infectious Diseases Society of America.
Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 189-92. PMID: 8207177, DOI: 10.1086/646888.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsInfectious Diseases SocietyQuality Standards SubcommitteeTreatment of bacteremiaDiseases SocietyBlood culturesChart reviewersAdverse outcomesPediatric Infectious Diseases SocietyPlacebo-controlled trialPresence of bacteremiaSerious adverse outcomesSurgical Infection SocietyAdministration of antibioticsAppropriate antimicrobial treatmentClinical Affairs CommitteeCase-control studyPositive blood culturesSpecific clinical indicationsAppropriate dosingRenal failureHospitalized patientsProlonged hospitalizationRisk factorsClinical indicationsClinical trials